orforglipron vs semaglutide Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes Oral Semaglutide Demonstrates Greater Weight

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial

You may need to change your semaglutide dose or temporarily stop taking this medication in certain situations that can result in changes in blood glucose levels, for example, changes in diet and exercise, infections, illnesses, injuries, or emotional stress

(2021, September 2)

The study will generate new knowledge for researchers and healthcare providers to better understand which weight loss approach can best help women with overweight who want to become pregnant

If you are still experiencing side effects from tirzepatide, your provider may suggest waiting until they resolve before beginning semaglutide